-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O5.6 905. Outcomes Research—Lymphoid Malignancies: Health Outcomes in CAR T and Stem Cell Transplantation

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, ALL, adult, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, epidemiology, Clinical Research, health outcomes research, Workforce, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Combination therapy, pediatric, Diseases, immune mechanism, real-world evidence, Therapies, immunology, aggressive lymphoma, therapy sequence, Lymphoid Malignancies, Adverse Events, metabolism, young adult , Biological Processes, Technology and Procedures, Study Population, Human, multi-systemic interactions
Monday, December 12, 2022: 4:30 PM-6:00 PM
291-292 (Ernest N. Morial Convention Center)
Doris K. Hansen, MD, H. Lee Moffitt Cancer Center & Research Institution and Carlos A. Ramos, MD, The Methodist Hospital
Hansen: Survivorship: Honoraria; OncLive: Honoraria; BMS IMW Ide-Cel Academic Advisory Board: Membership on an entity's Board of Directors or advisory committees, Research Funding.
This session involves studies related to cellular immunotherapy and stem cell transplantation.
4:30 PM

Macarena Oporto Espuelas1*, Saskia Burridge2*, Denise Bonney, MD3*, Kelly Watts4*, Claire Roddie5*, Maeve A O'Reilly5, Geoff Shenton6*, John A Snowden7, Caroline Furness8*, Katarzyna Aleksandra Aleksandra Jalowiec, MD9*, Lorna Neill10*, Katherine Clesham, MD PhD11*, Emma Nicholson, MD, PhD12*, Anna Castleton, FRCPath13*, Amit Patel, MBBS, PhD, FRCPath, MRCP14, Caroline Besley, FRCPath, PhD15*, Robert F Wynn, MD16, Ajay Vora, MD17, David I. Marks, MBBS, PhD18, Lindsay George, PhD, FRCPath19*, Ben Uttenthal20*, Sridhar Chaganti, MD21*, Michelle Cummins22*, Persis J Amrolia, MD PhD2*, Rachael E Hough, MD23* and Sara Ghorashian, FRCPath, PhD24

1Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, LONDON, ENG, United Kingdom
2Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
3Department of Bone Marrow Transplantation, Royal Manchester, Manchester, United Kingdom
4Bone Marrow Transplantation, Royal Manchester Children's Hospital, Manchester, United Kingdom
5University College London Hospital NHS Foundation Trust, London, United Kingdom
6Newcastle Hospitals NHS Foundation, Newcastle-upon-Tyne, GBR
7BSBMTCT, Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
8Royal Marsden NHS Foundation Trust, royal marsden, London, United Kingdom
9Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
10Department of Haematology, University College London Hospitals NHS Foundation Trust, London, ENG, United Kingdom
11Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
12Department of Haematology/Bone marrow transplantation, The Royal Marsden NHS Foundation Trust, London, United Kingdom
13Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
14Haematology and Transplant Unit, The Christie Hospital, Manchester, United Kingdom
15University Hospitals Bristol, Bristol, United Kingdom
16Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom
17Department of Haematology, The Children's Hospital, London, United Kingdom
18Haematology and Stem Cell Transplantation, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
19Birmingham Children's Hospital, Birmingham, GBR
20Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
21Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
22Department of Haematology, Bristol Children's Hospital, Bristol, GBR
23Haematology, UCLH, London, United Kingdom
24Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom

4:45 PM

Veit L Buecklein, MD1,2*, Ariel Perez-Perez, MD3*, Kai Rejeski, MD2,4,5, Gloria Iacoboni, MD6*, Vindi Jurinovic, PhD7*, Udo Holtick, MD, PhD8*, Olaf Penack, MD9*, Soraya Kharboutli, MD10*, Viktoria Blumenberg, MD1,2,5, Josephine Ackermann2*, Lisa Frölich2*, Grace Johnson11*, Kedar Patel11*, Brian Arciola11*, Christian Schmidt, MD2*, Omar Albanyan, MD12, Philipp Gödel, MD13*, Eva Hoster7*, Lars Bullinger, MD9, Andreas Mackensen, MD14*, Frederick L. Locke, MD12, Michael von Bergwelt, Prof. Dr.2,5*, Pere Barba, MD15*, Michael D. Jain, MD, PhD16 and Marion Subklewe, MD1,5,17

1Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
2Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
3Blood & Marrow Transplant Program, Miami Cancer Institute, Miami, FL
4Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
6Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
7Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany
8Department I of Internal Medicine, Department I of Internal Medicine,, University Hospital Cologne, Department I of Internal Medicine,, Cologne, Germany
9Department of Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany
10Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
11USF Morsani College of Medicine, Tampa, FL
12Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
13University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany
14Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany
15Department of Hematology, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
16Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
17Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

5:15 PM

Ishan Roy1,2*, Narendranath Epperla, MD, MS3, Geoffrey Shouse, PhD, DO4, Jason T. Romancik, MD5, Tamara K. Moyo, MD, PhD6*, Vaishalee P. Kenkre, MD7, Thomas A. Ollila, MD8, Lindsey A. Fitzgerald, MD9, Brian T. Hess, MD10, Andrew M. Evens, DO, MBA, MMSc11, Joanna Zurko, MD7, Sayan Mullick Chowdhury, DO, PhD12*, Kaitlin Annunzio, DO13, Robert Ferdman, MD14*, Rahul S. Bhansali, MD15, Elyse I. Harris, MD16, McKenzie Sorrell, DO10, Jieqi Liu, MD17, Imran A. Nizamuddin, MD18, Jonathan Moreira, MD19, Shuo Ma, MD20, Jane N. Winter, MD21, Barbara Pro, MD22,23, Deborah M. Stephens, DO24, Alexey V Danilov, MD25, Nirav N. Shah, MD26, Jonathon B. Cohen, MD, MS27, Stefan K. Barta, MD28, Pallawi Torka, MD14, Leo I. Gordon, MD23 and Reem Karmali, MD, MSc29

1Shirley Ryan AbilityLab, Chicago, IL
2Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL
3The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
4Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
6Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
7Carbone Cancer Center, University of Wisconsin, Madison, WI
8Lifespan Cancer Institute, Brown University, Providence, RI
9Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
10Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
11Rutgers Cancer Institute of New Jersey, Warren, NJ
12Ohio State University Medical Center, Columbus, OH
13The Ohio State University, Columbus, OH
14Roswell Park Comprehensive Cancer Center, Buffalo, NY
15Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
16Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
17Rutgers Cancer Institute of New Jersey, Hoboken, NJ
18Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
19Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
20Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
21Feinberg School of Medicine, Northwestern University, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
22Department of Hematology and Oncology, Columbia University Medical Center, New York, NY
23Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
24Huntsman Cancer Institute, Salt Lake City, UT
25City of Hope Comprehensive Cancer Center, Duarte, CA
26Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
27Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
28Abramson Cancer Center, Lymphoma Program, University of Pennsylvania, Philadelphia, PA
29Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL

5:30 PM

Yadith Karina Lopez-Garcia, MD1*, Christianne Bourlon De Los Rios, MD, MSc2, Perla Rocio Colunga-Pedraza, MD1, Cesar Omar Vargas-Serafin, MD2*, Alberto Vazquez Mellado de Larracoechea3*, Lourdes Gil-Flores1, Nidia Moncada Saucedo1*, Moisés Manuel Gallardo-Pérez, MD4*, David Gomez-Almaguer, MD5, Guillermo José Ruiz-Argüelles, MD, FRCP (Glasg), MACP, DSc(hc), FRCP6 and Andres Gomez-De Leon, MD1

1Servicio de Hematología, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
2Department of Hematology and Oncology, Instituto Nacional De Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico
3Clínica Hematológica, Queretaro, Mexico
4Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico
5Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
6Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, PU, Mexico

5:45 PM

Dai Chihara, MD1, Laura Liao2*, Joseph Tkacz, MS3*, Benjamin Lewing, PhD3*, Anjali Franco, MS3*, Karl M. Kilgore, PhD3*, Loretta J. Nastoupil, MD1 and Lei Chen, MD, PhD2*

1MD Anderson Cancer Center, Houston, TX
2ADC Therapeutics America, Inc., New Providence, NJ
3Inovalon, Bowie, MD

*signifies non-member of ASH